Specifically, HNRNPM is implicated in the adaptation to a hypovascular environment [64]; while RBM5 expression inversely correlates with KRAS levels and is associated with clinicopathological features and appears to promote tumor progression [65]. This evidence concerns the gene RBM5 and neoplasm.